Events FDA Generic Medicine 
pharmaphorum
JANUARY 30, 2023
Moreover, more than any other medicine, antibiotics are more likely to face insufficient supply, with analysis by the US Pharmacopeia suggesting they are 42% more likely to be in shortage compared to all other drugs. Indeed, China plays a crucial role in the supply of antibiotics.
The Checkup by Singlecare
FEBRUARY 27, 2024
Food and Drug Administration (FDA) as an adjunct to be used along with an antidepressant medicine to treat major depressive disorder (MDD) in adults. It is also FDA-approved to treat schizophrenia in adults and children ages 13 and older and to treat agitation that may occur with dementia due to Alzheimer’s disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
FEBRUARY 10, 2025
Food and Drug Administration ( FDA ) in 2014 for Type 2 diabetes. Since then, its FDA -approved uses have expanded, now including kidney disease, heart failure , and Type 2 diabetes. As of 2024, Prasco has offered an authorized generic version of dapagliflozin (more on authorized generics below).
The Checkup by Singlecare
SEPTEMBER 18, 2023
Food and Drug Administration (FDA). It’s usually dispensed in pharmacies as a generic medicine, but healthcare providers commonly refer to it by brand names Flexeril (immediate-release tablets), Fexmid (immediate-release tablets), or Amrix (extended-release capsules). Flexeril is no longer made in the U.S. as a brand-name drug.
pharmaphorum
MAY 26, 2022
Factors such as ethnicity, gender, sexual orientation and age can contribute to interindividual differences in treatment responses and risks of adverse events. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines. Why are certain ethnic groups underrepresented?
Expert insights. Personalized for you.
104 
Let's personalize your content